http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2702634-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a09fa84c54c24536575f7f12c1f1db43
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14322
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-015
filingDate 1977-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c816312eccbc5c3625a300f435db67ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de35510ac5d34e308dcbddbee13004f3
publicationDate 1978-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-2702634-A1
titleOfInvention METHOD OF PRODUCING A VACCINE AGAINST PANLEUKOPENIA OF THE CAT
abstract In the prodn. of vaccines against feline panleukopenia virus pathogenic panleukopenia virus is passaged at least 80 times through cat kidney cells and then at least 18 times through permanent tissue cells of felids or mustelids, then the attenuated virus thus obtained increased on cat foetal cells and converted into a vaccine. Attenuated panleukopenia virus strain BW 103 is claimed. Used for immunisation for cats against panleukopenia (infectious gastoenteritis). The antigen is highly pure. Since the attenuated virus is raised on homologous tissues, allergic reactions to the vaccine are avoided. The method of raising the virus permits a product of uniform quality to be produced. The attenuated vaccine obtained gives more rapid protection than existing vaccines.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8001644-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103773739-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0023922-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103773739-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4303644-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4287178-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0023922-A1
priorityDate 1977-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00761
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35051
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35048
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35050
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19799
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51588
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35049
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35034
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00775
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00764
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO97399
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23916
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24664
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81071
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ59149
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559590
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83348
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP70059
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24523

Total number of triples: 41.